학술논문

MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma

Document Type

Article

Author

Zonder, J.A.; Richter, J.; Jagannath, S.; Bumma, N.; Brayer, J.; Hoffman, J.E.; Bensinger, W.I.; Wu, K.L.; Xu, L.; Chokshi, D.; Boyapati, A.; Cronier, D.; Houvras, Y.; Lorenc, K.R.; Kroog, G.S.; Dhodapkar, M.V.; Lentzsch, S.; Cooper, D.

Source

In: Clinical Lymphoma, Myeloma and Leukemia, Proceedings of the Society of Hematologic Oncology 2022 Annual Meeting. (Clinical Lymphoma, Myeloma and Leukemia, October 2022, 22:S406-S407)

Subject

Language

English

ISSN

21522669
21522650

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송